Global Pharmaceutical Technology :: A Best B2B solution, Best Media Portal for Pharmaceutical Industry.

Neurim Pharmaceuticals (http://www.Neurim.com ) confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia  in patients who are aged 55 or over.

Par Pharmaceutical Companies, Inc. today announced that it began shipping the 20mg/1100mg and 40mg/1100mg strengths of omeprazole and sodium bicarbonate capsules to the trade.

A product manufactured incorporating innovative technology makes it possibly the most preferred product in the market. Most revered organizations spend millions everyday to carry out scientific research and development in order to stay ahead of competition.

Life sciences, talk of drug development and DNA summons up bad memories of high school chemistry labs and all-nighters spent cramming for biology midterms. (Confession: I was barely a C student in both subjects.)